Dynavax Technologies reported $31.47M in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Adma Biologics ADMA:US $ -14815070 1.62M
Agenus AGEN:US $ -35997000 20.08M
Amgen AMGN:US $ 2500M 196M
AstraZeneca AZN:LN 2.88B 1.57B
Astrazeneca AZN:US 2.88B 1.57B
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bristol Myers Squibb BMY:US $ 3188M 399M
Chimerix CMRX:US -24771000 14.76M
Dynavax Technologies DVAX:US $ 31.47M 49.67M
Gilead Sciences GILD:US $ 2897M 1957M
Glaxosmithkline GSK:US 2.42B 724M
Idera Pharmaceuticals IDRA:US $ -4182000 61K
Merk MRK:US $ 5059M 207M
Minerva Neurosciences NERV:US $ -7989260 13.39M
Nektar Therapeutics NKTR:US $ -115085000 2.17M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Tg Therapeutics TGTX:US $ -66872000 26.08M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M